Based on both in vivo and in vitro studies, we have shown previously that t
he intracellular domain of a membrane-bound isoform of the growth factor, n
euregulin, regulates proteolytic release of its extracellular domain ErbB r
eceptor-activating ligand. To investigate the mechanism(s) involved in this
regulation, a series of intracellular domain mutants were constructed and
tested for susceptibility to proteolytic processing after transient transfe
ction in COS-7 cells. These studies revealed that regulation of extracellul
ar domain cleavage by the intracellular domain is sequence-specific and inv
olves three distinct 30-60-residue segments. The presence of any two of the
se three segments is both necessary and sufficient for proteolytic processi
ng, and resistance to proteolysis is not due to an alteration in cellular l
ocalization or transport. Evidence was also obtained that regulation of ext
racellular domain processing involves initial intracellular domain dimeriza
tion. Thus, with expression of a construct encoding only the intracellular
domain, dimerization could be demonstrated in cross-linking experiments. Fu
rthermore, resistance to proteolytic processing of a construct lacking a la
rge portion of the intracellular domain was rescued with a chimera, in whic
h the intracellular domain was replaced with a spontaneously dimerizing Fc
fragment. Taken together these studies indicate that intracellular domain i
nteractions are critically involved in the spacial and temporal control of
growth and development by membrane-bound neuregulin isoforms.